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The outer membrane protease Pla belongs to the omptin protease family spread by
horizontal gene transfer into Gram-negative bacteria that infect animals or plants. Pla has
adapted to support the life style of the plague bacterium Yersinia pestis. Pla has a β-barrel
fold with 10 membrane-spanning β strands and five surface loops, and the barrel surface
contains bound lipopolysaccharide (LPS) that is critical for the conformation and the activity
of Pla. The biological activity of Pla is influenced by the structure of the surface loops
around the active site groove and by temperature-induced LPS modifications. Several
of the putative virulence-related functions documented for Pla in vitro address control
of the human hemostatic system, i.e., coagulation and fibrinolysis. Pla activates human
plasminogen to the serine protease plasmin and activates the physiological plasminogen
activator urokinase. Pla also inactivates the protease inhibitors alpha-2-antiplasmin and
plasminogen activator inhibitor 1 (PAI-1) and prevents the activation of thrombin-activatable
fibrinolysis inhibitor (TAFI). These functions enhance uncontrolled fibrinolysis which
is thought to improve Y. pestis dissemination and survival in the mammalian host,
and lowered fibrin(ogen) deposition has indeed been observed in mice infected with
Pla-positive Y. pestis. However, Pla also inactivates an anticoagulant, the tissue factor
(TF) pathway inhibitor, which should increase fibrin formation and clotting. Thus, Pla and
Y. pestis have complex interactions with the hemostatic system. Y. pestis modifies its LPS
upon transfer to the mammalian host and we hypothesize that the contrasting biological
activities of Pla in coagulation and fibrinolysis are influenced by LPS changes during
infection.
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Yersinia INFECTIONS AND THE HEMOSTATIC CONTROL
The hemostatic mechanism consists of three main phases: pri-
mary hemostasis, in which platelets form a hemostatic plug
stabilized by fibrin strands; secondary hemostasis i.e., coagula-
tion cascade, which involves a series of linked proteolytic reac-
tions that result in fibrin formation; and tertiary hemostasis in
which several mechanisms counteract coagulation processes and
induce fibrinolysis (reviewed by van Gorp et al., 1999). The latter
involve circulating inhibitors of blood coagulation, endothelium-
bound modulators, as well as endothelium-released activators of
plasminogen. The plasminogen activators convert the abundant
circulating plasminogen to the serine protease plasmin which
degrades fibrin and also has a wealth of functions in tissue remod-
eling and cell migration (reviewed by Myöhänen and Vaheri,
2004; Schaller and Gerber, 2011).
Systemic bacterial infections are a well-known activator of
the coagulation cascade, and the activation results from a com-
plex action of bacterial factors, host cytokines, and plasma pro-
teins (reviewed by van Gorp et al., 1999; Sun, 2006; Semeraro
et al., 2012). The clotting system normally minimizes blood
loss and also modulates innate immune responses, and physi-
cally prevents, through fibrin deposition, the spread of invasive
bacteria (Yun et al., 2009). In sepsis caused by Gram negative
bacteria, the main route for activation of the coagulation cas-
cade is the tissue factor (TF) pathway triggered as a response
to endotoxin and/or inflammatory cytokines. Coagulation is
preceded by primary fibrinolysis, where tumor necrosis fac-
tor (TNF) mediates a transient increase in the levels of tissue
type plasminogen activator (tPA) and urokinase plasminogen
activator (uPA). This is followed by an increase in plasmino-
gen activator inhibitor 1 (PAI-1) that indirectly suppresses fib-
rinolysis and favors coagulation and fibrin deposition. Fibrin
formation triggers a secondary activation of fibrinolysis, which
is rapidly shut-off by the release of high amounts of PAI-1,
leading to a procoagulant state as the net effect (van Gorp
et al., 1999). Massive thrombin formation and fibrin deposi-
tion in bacterial sepsis thus involve overexpression of inflam-
matory mediators, the microbe(s) and its derivatives, aberrant
expression of TF, impairment of physiological anticoagulant
pathways, and suppression of fibrinolysis by PAI-1 (Semeraro
et al., 2012). Overwhelming infection can lead to severe unbal-
ance in the system, prompting thrombin and fibrin formation
or, in more severe case, disseminated intravascular coagula-
tion (DIC) with formation of microvascular thrombi in vari-
ous organs. DIC eventually consumes blood-clotting factors and
thus subsequently contributes to hemorrhage, so thrombosis and
Frontiers in Cellular and Infection Microbiology www.frontiersin.org July 2013 | Volume 3 | Article 35 | 1
CELLULAR AND INFECTION MICROBIOLOGY
Korhonen et al. Hemostasis unbalance caused by Yersinia pestis
bleeding may both be presenting clinical features (van Gorp et al.,
1999).
Infections by species of Yersinia alter the hemolytic balance and
their pathogenesis is influenced by coagulation and fibrinolysis
factors. Fibrinogen/fibrin deposition has been observed in infec-
tions by Yersinia pseudotuberculosis (Caruso, 1986; Fisher et al.,
2007), which is the genetically closest species to Y. pestis. Luo
et al. (2011) found that fibrinogen-deficient mice show increased
hepatic bacterial burden and mortality following i.p. or i.v. inoc-
ulation with Yersinia enterocolitica. The fibrinogen-deficient mice
displayed impaired cytokine and chemokine production and sup-
pressed neutrophil recruitment. Similar outcome and phenotype
were observed in mice with low TF activity and in mice deficient
for PAI-1 or for thrombin-activatable fibrinolysis inhibitor (TAFI;
Luo et al., 2011). These mutations cause fibrin deficiency in mice,
and it was concluded that TF, PAI-1, and TAFI have critical roles
in host defense against the bacteria. On the other hand, fibrin also
facilitates both innate and T cell-mediated defense againstYersinia
pestis (Luo et al., 2013) Y. enterocolitica as well as Y. pseudotubercu-
losis infections mostly manifest as self-limiting enterocolitis, but
the bacteria can occasionally also cause sepsis. The highly inva-
sive Y. pestis possesses the Pla protease that in vitro degrades both
PAI-1 and TAFI, as will be discussed below, and is able in vivo
to overcome fibrin-mediated physical entrapment and inflam-
matory reactions caused by the bacteria (Degen et al., 2007). A
functional homolog of Pla is lacking in Y. pseudotuberculosis as
well as in Y. enterocolitica, and the presence or absence of Pla in
these three species has a profound impact on their interactions
with the hemolytic system.
The evidence for the role of Pla in the virulence of Y. pestis
is strong. Transcription analyses have shown that the pla gene is
expressed in buboes, the lung, the spleen, and the liver of Y. pestis-
infected mice (Sebbane et al., 2006; Lathem et al., 2007; Liu et al.,
2009). Deletion of pla increases the LD50 value million fold in
mice infected subcutaneously (Sodeinde et al., 1992), and in the
pneumonic form of plague, proteolytically active Pla promotes
bacterial proliferation in the lungs (Lathem et al., 2007). However,
Pla is dispensable in primary septicemia plague (Sebbane et al.,
2006), where the flea injects bacteria directly into the blood ves-
sels, and the deletion of pla does not change the LD50 when the
mice are infected intravenously or intraperitoneally (Sodeinde
et al., 1992). On cellular level, it is known that in bubonic plague
Pla enables bacterial dissemination from the skin to the lymph
nodes where Y. pestis multiplies and causes swollen lymphs, or
buboes (Sodeinde et al., 1992). Guinet et al. (2008) observed
that bacterial loads of Pla-positive Y. pestis became higher than
those of wild type (i.e., Pla-deficient) Y. pseudotuberculosis in
rat lymph nodes at 24–48 h after infection when also signifi-
cant histopathological changes were evident. They concluded that
Y. pseudotuberculosis infection induced an organized leukocyte
response that was not seen with Y. pestis. Thus, the role of Pla in
plague seems to be restricted to enhancement of bacterial migra-
tion from the intradermal infection site into lymph nodes and to
their proliferation in buboes and the lungs.
Secreted proteases targeting human coagulation or fibrinol-
ysis proteins have been described in other pathogenic bacteria
as well, e.g., Pseudomonas aeruginosa, Bacillus anthracis, and
Staphylococcus aureus (Beaufort et al., 2008, 2010; Chung et al.,
2011). Two main features distinguish Pla from these extracel-
lular proteases. First, Pla is a transmembrane, cell-wall associ-
ated protease/adhesin that can cause surface-bound proteolysis
to optimally advance cell migration across fibrin deposits and
subepithelial basement membranes. This analogy to behavior of
metastatic cancer cells led us to the concept of bacterial metas-
tasis (Lähteenmäki et al., 2005a) to underline that migration of
prokaryotic and eukaryotic cells across tissue barriers is based
on similar principles. By contrast, the enzymes of P. aerugi-
nosa, B. anthracis, and S. aureus are secreted to cell surroundings
where their concentration and activity will be diluted. Second,
in cleaving plasminogen, PAI-1, and single chain uPA (scuPA),
Pla shows awesome cleavage site specificity not seen with the
secreted proteases. Here we will discuss the fibrinolytic and coag-
ulative activities that have been characterized for the Pla protease.
Pla also has other proteolytic functions as well as adhesive and
invasive activities, and for recent more general reviews on Pla
and omptins, the reader is referred to Haiko et al. (2009b) and
Caulfield and Lathem (2012).
STRUCTURE-FUNCTION RELATIONSHIPS OF Pla
STRUCTURE
Omptins are monomeric β-barrel proteins with 10 antiparal-
lel β-strands, and the crystal structures of OmpT of E. coli
(Vandeputte-Rutten et al., 2001) and Pla have been resolved (Eren
et al., 2010; Eren and van den Berg, 2012). The connecting loops
on the periplasmic side of the barrel are short (2–4 amino acids)
but the five surface-exposed loops (L1–L5) are long and variable
in sequence between different omptins. The barrel length is about
70 Å of which 30 Å is located inside the lipid bilayer in the outer
membrane, as determined by the two girdles of hydrophobic
amino acids (Figure 1).
The catalytic residues are conserved in all omptins (Kramer
et al., 2001; Vandeputte-Rutten et al., 2001; Haiko et al., 2009b,
2010) and have been identified in Pla as D84, D86, D206, and
H208 (Kukkonen et al., 2001; Eren et al., 2010; Eren and van
den Berg, 2012). β-barrel structures are unique to bacterial outer
membrane proteins, and the omptin active site residues cross the
barrel opening: D84–D86 dyad lying on one side of it and D206–
H208 on the opposite side. In earlier work (Eren et al., 2010),
a water molecule was seen to connect the two pairs of catalytic
residues and was assumed to act as the reactive nucleophile, but
in the most recent crystal structure (Eren and van den Berg, 2012)
the bound substrate has replaced the water molecule. In addi-
tion, S99 and H101 in the vicinity of the active site are important
for enzymatic activity of Pla (Kukkonen et al., 2001) since they
coordinate the D84–D86 dyad via bridging water molecules (Eren
et al., 2010).
CLEAVAGE SPECIFICITY
Omptins are endopeptidases that cleave proteins preferentially
between basic amino acids (Dekker et al., 2001; McCarter et al.,
2004; Hwang et al., 2007; Agarkov et al., 2008). This preference,
obtained from quantitative studies with small peptide substrates
(2–10 amino acids), does not completely hold for the physio-
logical substrates, where usually only the first position is basic,
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FIGURE 1 | Overall structure of the Pla protein, oriented perpendicular
to the membrane plane, exracellular side up. The peptide chain is shown
as white strands, and the extracellular loops are colored (L1–L5). The yellow
spheres show positions of the active site residues (named) and the white
spheres locate conserved residues at the bottom of the active site. On the
right side of the image, LPS and the amino acids that contact it are shown
in stick models (gray and black, respectively). The figure is modified from
the crystal structure of Pla (Eren et al., 2010; Eren and van den Berg, 2012).
while the second position varies. Pla cleaves plasminogen between
residues R561 and V562, PAI-1 at R346-M347, and scuPA at
K148-K149, and Pla also autoprocesses itself between residues
K262–N263. In all these target molecules, the cleavage is a single
cut of a peptide bond located in an accessible loop structure.
Omptins share high sequence identities and their structures
are very similar, but they differ in polypeptide substrate speci-
ficity. Detailed analysis of the crystal structures suggests (Eren
et al., 2010; Eren and van den Berg, 2012) that minor changes
in the Pla barrel dimensions control enzymatic activity. The sub-
stitution analyses and chimera constructions have shown that
the functional heterogeneity of omptins results from sequence
variations in the surface loops that border the barrel open-
ing (Kukkonen et al., 2001; Ramu et al., 2008; Haiko et al.,
2011). Thus, the omptin catalytic amino acids are spatially
highly conserved, but the specific loop composition is an essen-
tial feature that distinguishes Pla functions from those of other
omptins and allows correct recognition of large polypeptide
substrates.
Omptins have been earlier classified either as serine proteases
or aspartate proteases but the more is known about them, the
more clearly they seem to form a protease class of their own
(Kramer et al., 2001; Vandeputte-Rutten et al., 2001; Eren et al.,
2010; Eren and van den Berg, 2012). This consideration stems
from their proposed cleavage mechanism, resistance to classical
protease inhibitors, neutral pH-optimum, and dependency on
bound lipopolysaccharide (LPS). Very recently, we have recorded
data that seems to question the well-accepted definition of omptin
active site: the Pla mutants D86A, D206A, H208V are inactive in
plasminogen activation, as seen before (Kukkonen et al., 2001),
but are able to cleave and activate precursor of the human plas-
minogen activator uPA (Järvinen et al., 2013). Clearly, details of
the reaction mechanism of omptins still remain unknown and
need further clarification.
BOUND LIPOPOLYSACCHARIDE ACTIVATES Pla
Omptins are unique proteases in that they require rough (short O
side chain) LPS to be active (Kramer et al., 2000, 2002; Kukkonen
et al., 2001, 2004; Brandenburg et al., 2005; Suomalainen et al.,
2010). A consensus protein motif for binding to 4′-phosphate
in lipid A (Ferguson et al., 2000) is present in the omptin
barrel (Vandeputte-Rutten et al., 2001) and consists of R138
and R171 in Pla. Substitution of these arginines, in particu-
lar R138, decreases Pla enzymatic activity and the amount of
Pla in cells (Suomalainen et al., 2010). Pla also binds LPS acyl
chains via Y134 and E136, and removal of LPS causes subtle
conformational changes that lead to inactivation of Pla (Eren
et al., 2010). The biggest structural differences between LPS-
depleted and LPS-containing Pla are observed in loops L4 and
L5, i.e., near the binding site of LPS (Eren and van den Berg,
2012). LPS binding induces narrowing of the active site groove
by pushing of the β7-strand inward, which affects the active site
geometry. In the absence of LPS, Pla substrate binds deeper in
the active site groove and replaces the water molecules essential
for the proteolytic mechanism (Eren and van den Berg, 2012).
Smooth LPS molecules with long O side chains extend much
further out from the bacterial surface than the surface loops of
omptins, and thus sterically hinder the loops from recognizing
the substrates (Kukkonen et al., 2004). Y. pestis lacks genes for
O side chain synthesis and therefore has rough LPS and thus
active Pla (Skurnik et al., 2000; Prior et al., 2001; Kukkonen
et al., 2004). Other bacteria, such as Salmonella enterica serovar
Typhimurium, modify their LPS structure inside mammalian
cells, where the omptin activity is high (Lähteenmäki et al.,
2005b).
MODIFICATIONS IN LPS INFLUENCE Pla ACTIVITY
Plague is a zoonotic disease, where the bacterium is transmitted to
mammals by a bite of an infected flea; the change of host involves
change of temperature from 20–25◦C to 37◦C. Y. pestis modifies
its LPS structure upon this temperature shift, and while the LPS
is mostly in the tetra-acylated form and the lipid A phosphates
are poorly substituted with 4-amino arabinose at 37◦C, at 25◦C
the LPS is mostly hexa-acylated and heavily substituted at lipid A
phosphates (Kawahara et al., 2002; Knirel et al., 2005). It is well-
established that the Y. pestis LPS from 37◦C is poorly recognized
by Toll-like receptor 4 and hence elicits only poor inflammatory
response in mouse and human macrophages, whereas the reverse
is true for Y. pestis LPS from 25◦C (Kawahara et al., 2002; Knirel
et al., 2005; Montminy et al., 2006). Thus, the lipid A alteration is
essential for evasion of innate immunity responses by Y. pestis.
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The temperature shift and the LPS alterations also affect the
functions of Pla. The activity of Pla in Y. pestis is dramati-
cally higher in cells grown at 37◦C than in cells grown at 20◦C
(Suomalainen et al., 2010). The expression of Pla is only mod-
estly up-regulated at 37◦C (Motin et al., 2004; Chromy et al.,
2005) and the high activity of Pla in cells from 37◦C results
from temperature-induced LPS alterations. Reactivation of LPS-
depleted His6-Pla with LPSs from three Y. pestis strains gave
higher activity with LPSs from 37◦C than from 25◦C, and anal-
yses with characterized LPS molecules showed that the critical
features were (1) the presence of a complete core region in the
rough LPS, and (2) low levels of acylation and phosphate substi-
tution in lipid A (Suomalainen et al., 2010), which all characterize
the Y. pestis LPS in cells grown at 37◦C. Exactly how these LPS
modifications change the conformation of Pla is not known at
the moment. Biology considered, the host shift from the flea to
the mammal however represents a huge difference in pathogenic
potential: at 20–25◦C, i.e., in the flea and at early stages of infec-
tion in the mammal host, Y. pestis is associated with high innate
immune response and low activity of Pla, whereas at 37◦C the
situation is reversed.
Pla ENHANCES FIBRINOLYSIS
The hemostatic processes and reactions affected by Pla are
shown in Figure 2, the evidence mainly comes from in vitro
experiments. The first function observed for Pla was activa-
tion of human plasminogen, but recent research has shown
that Pla has a broad activity on hemostatic processes and
disrupts its control at various stages. Fibrinolysis is plasmin-
mediated degradation of fibrin, and the system is composed
of several proteins (serine proteases, their inhibitors, cellular
receptors) that interact to regulate the generation of plasmin
(reviewed by Vaughan and Declerck, 2003). The control occurs
at the levels of protein-protein interactions and at the cellu-
lar level where the synthesis of fibrinolysis proteins are highly
regulated.
ACTIVATION OF PLASMINOGEN
Plasminogen is an abundant circulating zymogen of plasmin syn-
thesized primarily in the liver. Pla cleaves plasminogen at the
same peptide bond R560-V561 as do the human physiological
activators, uPA and the tissue-tPA, which yields the two-chain
active enzyme plasmin (Sodeinde et al., 1992). The plasmin
A chain contains lysine-binding domains (“kringles”) interact-
ing with fibrin and with the plasmin inhibitor α2-antiplasmin
(α2AP). Exposed lysines in fibrin or on cell surfaces and α2AP
compete for binding to kringles, and therefore immobilization
of plasmin on fibrin or on cell surfaces protects plasmin from
inactivation by α2AP; lysine binding thus contributes to local-
ization of plasmin proteolysis (Vaughan and Declerck, 2003).
FIGURE 2 | Interactions of Pla with the hemostatic system. Pla
enhances fibrinolysis directly by activating plasminogen to plasmin and
indirectly by inactivating the antiprotease plasminogen activator inhibitor-1
(PAI-1), by activating the precursor of the plasminogen activator
urokinase, and by inactivating the plasmin inhibitor α2-antiplasmin (α2AP).
Fibrin degradation allows bacterial dissemination and reduces
engagement of neutrophils at the infection foci, which is also affected by
the Pla-mediated cleavage of the C3 complement protein. Pla favors
coagulation by activating the precursor of the enzyme Factor VII (FVII)
and by inactivating the anticoagulant tissue factor pathway inhibitor
(TFPI). Fibrin traps bacteria and decreases their dissemination, it also
increases leukocyte engagement.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org July 2013 | Volume 3 | Article 35 | 4
Korhonen et al. Hemostasis unbalance caused by Yersinia pestis
The B chain of plasmin contains the protease catalytic domain.
Plasmin is a broad-spectrum serine protease that regulates fibri-
nolysis. It cleaves fibrin and fibrinogen at specific K-X and R-X
bonds to produce small soluble degradation products (reviewed
by Greenberg and Lai, 2003). Pla increases plasmin formation
also indirectly by cleaving the zymogen form of uPA by a single,
activating cut (Järvinen et al., 2013; see below).
Plasmin also enhances migration of phagocytic cells and
metastatic tumor cells indirectly, through activation of latentmet-
alloproteinases (MMPs) that degrade collagens, and also directly,
by degrading laminin (Myöhänen and Vaheri, 2004; Schaller and
Gerber, 2011). Thus, plasmin formation by Pla likely enhances
migration of Y. pestis through main tissue barriers made up
by inflammatory fibrin and basement membranes. Engagement
of fibrin through αMβ2 integrins on leukocyte surface is crit-
ical for leukocyte function (Flick et al., 2004), and another
outcome of fibrin degradation or deficiency during bubonic
plague is reduced activation of macrophages and neutrophils and
lower local inflammatory response at the infection site (Degen
et al., 2007). Fibrin also supports neutrophil-dependent T cell-
mediated defense in mice against Y. pestis (Luo et al., 2013) Also,
Pla degrades in vitro the complement protein C3, which should
reduce trafficking of inflammatory cells to the infecton foci in
plague (Sodeinde et al., 1992).
Infection studies in plasminogen-deficient and fibrinogen-
deficient mice support the essential role of plasminogen as a
Pla substrate. Although the general health of the plasmino-
gen deficient mice is poor, they show increased resistance to
Y. pestis infection, which underlines the role of plasmin forma-
tion in plague virulence (Degen et al., 2007). On the contrary,
fibrinogen-deficient mice show increased sensitivity to infection
which underlines the protective role of fibrin(ogen) in bubonic
plague. In normal mice fibrin(ogen) deposition was reduced in
liver lesions after Pla-positive Y. pestis infection (Degen et al.,
2007). Also, expression of Pla during pneumonic plague asso-
ciates with fibrin degradation (Lathem et al., 2007). Interestingly,
Lathem et al. (2007) observed that deletion of pla dramatically
decreases inflammatory cytokine response in intranasally infected
mice, and concluded that Pla allows Y. pestis to cause lethal fulmi-
nant pneumonia in the lungs. It remains to be analysed whether
this is a direct action of Pla protease on lung cells or an indirect
effect resulting from increased cell numbers and translocation
of type III secretion effector proteins into host cells (Akopyan
et al., 2011). Pla could potentiate growth of Y. pestis in the lungs
through cleavage of pulmonary antimicrobial peptides (Galvan
et al., 2008). In this context, it is interesting that OmpT has
been suggested to induce cytokine responses independently of the
omptin-bound LPS (Brandenburg et al., 2005).
The pla gene is located in the pPCP1 virulence plasmid, and
its predicted mature amino acid sequence is 100% identical in all
pandemic Y. pestis branches. However, comparative genomics and
substitutional analyses indicate that Pla has evolved since the gene
was introduced into Y. pestis. The plague bacterium has diverged
from Y. pseudotuberculosis which lacks pla, and the ancestral, non-
pandemic lineages Microtus and Angola of Y. pestis carry Pla with
I259, whereas the modern, pandemic lineages have T259 (Song
et al., 2004; Haiko et al., 2009a; Eppinger et al., 2010). The change
results from a single nucleotide substitution, and in vitro analy-
ses showed that this substitution dramatically increases stability
of the formed plasmin by preventing degradation of the B chain
of plasmin by Pla (Haiko et al., 2009a). Pla in the modern lineages
cleaves the plasminogen molecule at a single cut and is so far the
only known omptin with T259 and with the ability to create sta-
ble plasmin activity. The others, such as PgtE of S. enterica, enable
only transient plasmin activity as they also cleave the B chain,
while others, such as OmpT of E. coli, cleave the plasminogen
molecule poorly or not at all (Haiko et al., 2009b). This indicates
that Pla has evolved toward creating stable plasmin activity and
limited cleavage of the plasminogen molecule.
ACTIVATION OF scuPA
uPA is the physiological plasminogen activator associated with
enhancement of cell migration and tissue remodeling, whereas
tPA associates with fibrin degradation (Crippa, 2007; Schaller and
Gerber, 2011). Synthesis and secretion of scuPA is upregulated in
inflammatory environment by e.g., neutrophils recruited at the
infection site, and it is secreted as a 411 amino acids-long zymo-
gen that is processed to active uPA by plasmin and kallikrein.
scuPA and uPA have receptors on several cell types, and uPA
favors cell migration also by non-proteolytic processes (Montuori
et al., 2013). Pla and several other omptins activate scuPA in vitro
by a single cut at the peptide bond that is cleaved also by the phys-
iological scuPA activator plasmin (Järvinen et al., 2013). PAI-1
binds to activated uPA and inhibits plasminogen activation, hence
cleavage of PAI-1 by Pla (see below) may release this control and
lead to uncontrolled plasmin formation by uPA.
INACTIVATION OF SERINE PROTEASE INHIBITORS
Serine protease inhibitors (serpins) are a major class of abundant
protease inhibitors circulating in the human body and have an
important role in controlling endogenous proteolysis and tissue
remodeling. Serpins inhibit proteases by inserting their reactive
center loop, which contains a bait peptide bond that mimics the
normal target of the protease, into the catalytic groove of the tar-
get enzyme, where an irreversible covalent bond is rapidly formed
and inactivates the enzyme. PAI-1 is present in a large variety of
tissues and secreted by several human cells and a key controller of
endogenous plasminogen activation by the serine proteases tPA
and uPA (reviewed by Vaughan and Declerck, 2003; Schaller and
Gerber, 2011). Pla cleaves the bait peptide bond R346-M347 in
PAI-1 (Haiko et al., 2010) and thereby rapidly prevents its action
to inhibit plasminogen activation. In circulation, most PAI-1 is
bound to vitronectin which increases its stability; Pla degrades
in vitro both PAI-1 and vitronectin present in the complex (Haiko
et al., 2010). The circulating plasmin inhibitor α2AP is also inhib-
ited and cleaved by Pla in a single, rapid cut (Kukkonen et al.,
2001), and although not determined chemically, the cleavage
most likely targets the bait peptide bond. Taken together, the ser-
pinolytic activities of Pla disrupt the control of both plasminogen
activation and plasmin activity, which then leads to uncontrolled
proteolysis to advance bacterial migration and survival.
Besides inhibiting generation of the key enzyme plasmin and
having a central role in maintaining normal hemostasis, PAI-
1 has been implicated in processes such as wound healing,
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atherosclerosis, angiogenesis, and cell migration (Lijnen, 2005;
van de Craen et al., 2012). Levels of PAI-1 are increased in infec-
tions by several Gram-negative pathogens, including Y. pestis, and
are associated with unfavorable outcomes and enhanced mortal-
ity (Park et al., 1997; Zeeleder et al., 2006; Song et al., 2007; Comer
et al., 2010; Kager et al., 2011; Lim et al., 2011). In accordance,
infection models in PAI-1 knockout mice have shown that PAI-1
is protective in defense against sepsis caused byKlebsiella pneumo-
niae, Burkholderia pseudomallei, and Y. enterocolitica (Renckens
et al., 2007; Hua et al., 2011; Kager et al., 2011; Luo et al., 2011)
and lung infections by Haemophilus influenzae and P. aeruginosa
(Goolaerts et al., 2011; Lim et al., 2011). These studies indicate
that dampening the plasmin formation during acute inflamma-
tory response helps the host to control bacterial infections, and
contrariwise, inactivation of PAI-1 leads to low expression of pro-
inflammatory cytokines and chemokines and low recruitment of
leukocytes.
CLEAVAGE OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR
TAFI is an antifibrinolytic plasma protein that inhibits fibrinolysis
by removing C-terminal lysines from fibrin. This reduces binding
of plasminogen and tPA onto fibrin and thereby also impairs fib-
rinolysis. During coagulation, TAFI is activated to TAFIa, and the
activation is mediated by several proteases that include throm-
bin, plasmin, trypsin, and neutrophil elastase (Kawamura et al.,
2002; Marx et al., 2002). Pla cleaves TAFI near its C-terminus
and so decreases thrombin-mediated activation of TAFI as well
as antifibrinolytic potential of TAFIa (Valls Serón et al., 2010),
which should favor plasmin action and fibrinolysis during infec-
tion. The role of TAFI in plague pathogenesis deserves further
studies, in particular because TAFI has been found protective in
septic yersiniosis (Luo et al., 2011).
Pla ENHANCES COAGULATION
TF is a transmembrane protein which under normal circum-
stances is expressed by e.g., epithelium of the skin, bronchus, and
glomeruli but not by cells in contact with plasma (e.g., blood
cells and endothelium of vessels) (reviewed by Broze, 2003). The
expression of TF is induced in monocytes and endothelial cells by
LPS, cytokines, and several other stimuli. In the event of injury to
blood vessel wall, TF is exposed and complexes and activates the
serine protease factor VII (FVII) to FVIIa. In a series of proteolytic
activations, factors FIXa, and FXa and eventually the prothrom-
binase complex FXaFVa are formed (Sun, 2006). This complex
cleaves prothrombin to thrombin, which then cleaves fibrinogen
to fibrin and causes coagulation. Coagulation, fibrinolysis, and
anticoagulation maintain a delicate physiological balance, and
the main function of the anticoagulation system is to prevent or
slow the propagation of fibrin clots. The major anticoagulants are
antithrombin, protein C, and TFPI.
CLEAVAGE OF TFPI
TFPI negatively regulates the coagulation system by inhibiting
FXa and the TF-FVIIa complex. The endothelium is presumed
to be the major source of TFPI in vivo, and a significant amount
of TFPI remains membrane-associated. Unlike levels of PAI-1,
the TFPI levels in plasma seem not to vary in response to e.g.,
pneumonia, and it was concluded that TFPI does not behave
as an acute-phase reactant (Broze, 2003). On the other hand,
TFPI is sensitive to inactivation by several host proteases (such as
MMPs, elastase, thrombin, FXa, and plasmin), which are released
from leukocytes or upregulated in coagulation, and TFPI inacti-
vation is thus expected to increase during infection (Yun et al.,
2009). Depletion of endogenous TFPI sensitizes rabbits to DIC
induced by TF or LPS, stressing the importance of TFPI as an
anticoagulant (Broze, 2003).
Yun et al. (2009) reported that Pla, as well as OmpT of E. coli
and PgtE of S. enterica, cleave and inactivate TFPI; interest-
ingly, as seen earlier with plasminogen as a substrate (Haiko
et al., 2009a,b), the omptins show differing cleavage patterns
of TFPI. Further, Pla, but not OmpT or PgtE, activated FVII
to FVIIa, which is a major target for TFPI. The authors esti-
mated that the inactivation rate of the naturally occurring, gly-
cosylated TFPI by Pla is significantly higher than plasminogen
activation by Pla and hence proposed that TFPI inactivation
and fibrin formation protect Y. pestis during early stages of
the infection. The estimation was, however, done before it was
known that Pla inactivates PAI-1 and activates scuPA and hence
probably underestimates fibrinolysis. The results however sug-
gest that Pla accelerates initiation of coagulation by activating
the first enzyme in blood-clotting (FVIIa) and inactivating its
principal inhibitor in plasma (Yun et al., 2009). Fibrin aug-
ments mouse immune defense against Y. pestis (Luo et al., 2013).
That efficient coagulation protects animals against plague is
suggested by the interesting finding that population of prairie
dogs in Arizona shows resistance to bubonic plague and has a
ten-fold higher serum level of TF than the neighboring popu-
lations suffering from plague (Busch et al., 2011). The resistant
prairie dog population also had a higher level of fibrinogen,
and overall, immune system expression was different in the two
populations.
CONCLUSIONS
Y. pestis and Pla have a complex repertoire of interactions with
the mammalian hemostatic system, and the observed in vitro
and in vivo reactions favor both fibrinolysis and coagulation. A
simple explanation would be that, once transmitted from the
flea to the mammalian host, the hexa-acylated LPS molecules of
Y. pestis cause a normal host response advancing coagulation.
This could be strengthened by Pla-mediated cleavage of TFPI
and activation of FVII and create a short-lived protective envi-
ronment for the bacterium, as suggested by Yun and Morrissey
(2009). Under these early conditions, the activity of Pla however
is low because of the LPS structure and initiation of the coag-
ulative cascade could be driven by the hexa-acylated LPS. Once
cell multiplication at 37◦C proceeds, the LPS is changed into the
form that favors Pla activity and suppresses both Toll-like recep-
tor 4-mediated immune response and fibrin-mediated leukocyte
recruitment. This hypothesis emphasizes LPS alteration as a reg-
ulator of Pla activity and plague pathogenesis. Several biological
aspects however remain unexplained. The activity of Pla in the
bubonic and the pneumonic plague has somewhat opposite cel-
lular effects. In bubonic plague, Y. pestis infiltrates lymph nodes
without inducing a leukocyte reaction, which is in accordance
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with emerging fibrinolytic activity of Pla. In the lungs, to the
contrary, Pla enables rapid replication of Y. pestis in the air-
ways and is needed to cause a fulminant cytokine expression at
the infection site. Transcriptomic analyses of coagulation-related
genes in plague infection mostly detect changes after 2 or 3 days
after the infection and have revealed increases in genes favoring
both fibrinolysis and coagulation. This also reflects the complex
and temporally diverse nature of the hemostatic system and the
multiplicity of factors that are involved. It is likely that more
host or Y. pestis factors targeting at Pla or targeted by Pla will be
identified and have a role in directing Pla functions toward fibri-
nolysis or coagulation. An interesting recent example is given in
the report that Pla proteolytically activates the YapE autotrans-
porter of Y. pestis and Y. pseudotuberculosis that contributes to
lymph node colonization during bubonic plague (Lawrence et al.,
2013).
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